We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated ce... Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Show more
SOUTH SAN FRANCISCO, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and...
- Sutro highlighted luveltamab tazevibulin (luvelta) in a January 2024 investor webcast, describing the broad opportunity to address unmet needs in multiple FolRα-expressing cancers...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.36 | -8.82352941176 | 4.08 | 4.23 | 3.55 | 649608 | 3.79246554 | CS |
4 | -0.12 | -3.125 | 3.84 | 6.13 | 3.42 | 1448771 | 4.70892673 | CS |
12 | -1.21 | -24.5436105477 | 4.93 | 6.13 | 3.2 | 1018511 | 4.56227167 | CS |
26 | 0.53 | 16.6144200627 | 3.19 | 6.13 | 2.005 | 945280 | 3.96136997 | CS |
52 | -0.99 | -21.0191082803 | 4.71 | 6.13 | 2.005 | 698101 | 4.17165369 | CS |
156 | -17.08 | -82.1153846154 | 20.8 | 23.7 | 2.005 | 558298 | 7.20528336 | CS |
260 | -6.28 | -62.8 | 10 | 28.3 | 2.005 | 423106 | 9.42045372 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions